Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b02dcb66c2b6a7ce7cce7d8ef91de480 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cba4b347abc2a14df2cc04e472cfb447 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7dbcdfe44cbd3872d311beed5c3e2673 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_00a421ab71bd49a451d0a49d23a082c7 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1305 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1311 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1317 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1335 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1388 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1364 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1382 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1341 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1376 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1323 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1394 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1329 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1347 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1352 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2502-1358 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0004 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0607 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5044 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-545 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
filingDate |
2014-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d698c62e2745f89ce1c43427a06e46b2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f3ccf536478028f897da73019933c8e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2167727b2c3fe7f15b627b9fb2d90ab3 |
publicationDate |
2014-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2014322135-A1 |
titleOfInvention |
Cell therapy for myelodysplastic syndromes |
abstract |
The invention provides methods for treating myelodysplastic syndrome (MDS). The invention is generally directed to reducing certain overt symptoms and disease-causing biological events in MDS by administering certain cells to a subject having MDS. The invention is also directed to drug discovery methods to screen for agents that modulate the ability of the cells to affect these events. The invention is also directed to cell banks that can be used to provide cells for administration to a subject, the banks comprising cells having desired potency for affecting these events. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020160274-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9861660-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11071752-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10967006-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10758570-B2 |
priorityDate |
2013-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |